Gilead Sciences Inc. logo

Gilead Sciences Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

61.09
 
USD
  
-0.82
  
(-1.32%)
Optionable: Yes  Market Cap: 74,682 M  90-day average vol: 7,189,670

Previous close: 61.91  Open: 61.79  Bid: 61.16  Ask: 61.16
52 week range    
57.17   
   74.12
Peers   
AMGN / 
VRTX / 
ABBV / 
BIIB / 
ILMN / 
MRK / 
PFE / 
JNJ / 
LLY / 
Last updated: Monday 8th August 2022
46
MarketXLS Rank marketxls
80
Value marketxls
7
Technical marketxls
52
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABBV

0.0401242 B33.1142.53

AMGN

0.0347129 B23.4223.53

BIIB

34 B21.6221.3

BIO.B

18 B2.6634

ILMN

56 B57.3355.92

JNJ

0.0247450 B22.1171.06

LLY

0.0161238 B37.4243.55

MRK

0.0356207 B28.877.58

PFE

0.0302298 B15.153.21

VRTX

63 B26.9243.26
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 89.543


Financials

GILD Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues9,702 M11,202 M24,890 M32,639 M30,390 M26,107 M22,127 M22,449 M24,689 M27,305 M
Cost of sales2,193 M2,514 M2,738 M2,908 M3,103 M3,085 M3,424 M3,271 M3,092 M4,551 M
Gross operating profit7,231 M8,343 M21,102 M28,633 M26,129 M21,736 M17,274 M17,774 M20,117 M20,704 M
Selling Gen & administrative expense1,461 M1,699 M2,983 M3,426 M3,398 M3,878 M4,056 M4,381 M5,151 M5,246 M
Research & development expense1,760 M2,120 M2,854 M3,014 M5,098 M3,734 M3,920 M4,055 M5,039 M5,363 M
Operating income4,010 M4,524 M15,265 M22,193 M17,633 M14,124 M9,298 M9,338 M9,927 M10,095 M
floaterest income0000000000
floaterest expense0000000000
Other income net-37 M-9 M3 M154 M428 M523 M-422 M-3,183 M-7,274 M-816 M
Pre-tax Income (EBT)3,612 M4,208 M14,856 M21,659 M17,097 M13,529 M7,799 M5,160 M1,669 M8,278 M
Income taxes1,038 M1,151 M2,797 M3,553 M3,609 M8,885 M2,339 M-204 M1,580 M2,077 M
Net income from total operations2,574 M3,057 M12,059 M18,106 M13,488 M4,644 M5,460 M5,364 M89 M6,201 M
Minority floaterest0000000000
Total net income2,592 M3,075 M12,101 M18,108 M13,501 M4,628 M5,455 M5,386 M123 M6,225 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common2,574 M3,057 M12,059 M18,106 M13,488 M4,644 M5,460 M5,364 M89 M6,201 M
Depreciation278 M345 M1,050 M1,098 M1,158 M1,286 M1,429 M1,404 M1,480 M2,050 M
Amortization0000000000
Operating income before depreciation (EBITDA)4,251 M4,860 M16,318 M23,445 M19,219 M15,933 M10,305 M7,559 M4,133 M11,329 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total1.712.017.9512.3710.083.544.24.240.14.96
Diluted EPS total1.641.817.3511.919.943.514.174.220.14.93
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!